Protagonist Therapeutics
PTGX
#4066
Rank
$2.29 B
Marketcap
$38.49
Share price
-0.10%
Change (1 day)
41.35%
Change (1 year)

Revenue for Protagonist Therapeutics (PTGX)

Revenue in 2024 (TTM): $0.32 Billion USD

According to Protagonist Therapeutics 's latest financial reports the company's current revenue (TTM ) is $0.32 Billion USD. In 2023 the company made a revenue of $60 Million USD an increase over the revenue in the year 2022 that were of $26.58 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Protagonist Therapeutics from 2015 to 2024

201620192022$0.1B$0.2B$0.3B$0.4B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) $0.32 B439.66%
2023 $60 M125.73%
2022 $26.58 M-2.84%
2021 $27.35 M-4.44%
2020 $28.62 M12293.07%
2019 $0.23 M-99.25%
2018 $30.92 M54.14%
2017 $20.06 M
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA